Analyzing molecular response in chronic myeloid leukemia clinical trials: Pitfalls and golden rules

Author： Guilhot Joëlle   Preudhomme Claude   Mahon Francois Xavier   Guilhot François  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|4|490-497

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.4, 2015-02, pp. : 490-497

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluating Treatment Response of Chronic Myeloid Leukemia: Emerging Science and Technology

By  

Current Cancer Drug Targets, Vol. 13, Iss. 7, 2013-09 ,pp. : 779-790

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Pathogenesis of Philadelphia-Positive Chronic Myeloid Leukemia - is it all BCR-ABL?

By  

Current Cancer Drug Targets, Vol. 11, Iss. 1, 2011-01 ,pp. : 3-19

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Trials in Children: Problems and Pitfalls

By Kauffman R.E.  

Pediatric Drugs, Vol. 2, Iss. 6, 2000-11 ,pp. : 411-418

Adis International

Access to resources Recommend Favorite

Treatment options for chronic myeloid leukemia

By Tanaka Maria Florencia   Kantarjian Hagop   Cortes Jorge   Ohanian Maro   Jabbour Elias  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 6, 2012-04 ,pp. : 815-828

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for chronic myeloid leukemia

By Cilloni Daniela   Messa Emanuela   Rotolo Antonia   Saglio Giuseppe  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 175-184

Informa Healthcare

Access to resources Recommend Favorite